SCHEMBL4529691

SCHEMBL4529691

CC(=Cc1nnn(-c2cccc(Cl)c2)n1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 4/20 0.46
PKM P14618 1/20 0.44
POLB P06746 1/20 0.40
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
HPGD P15428 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
HSD11B1 P28845 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3107652 0.78 PKM (0.46) GRM5PKMPOLBALDH1A1NPC1
SCHEMBL2889740 0.78 ALDH1A1 (0.48) GRM5PKMALDH1A1NPC1RAB9A
SCHEMBL2889744 0.78 ALDH1A1 (0.48) GRM5PKMALDH1A1NPC1RAB9A
SCHEMBL2966445 0.78 ALDH1A1 (0.48) GRM5PKMALDH1A1NPC1RAB9A
SCHEMBL2895448 0.77 GRM5 (0.45) GRM5PKMPOLBALDH1A1NPC1
SCHEMBL2889796 0.76 GRM5 (0.46) GRM5PKMPOLBALDH1A1NPC1
SCHEMBL2889795 0.76 GRM5 (0.46) GRM5PKMPOLBALDH1A1NPC1
SCHEMBL2962451 0.72 PKM (0.51) GRM5PKMPOLBALDH1A1NPC1
SCHEMBL5750726 0.70 PKM (0.37) GRM5PKMALDH1A1KMT2AMEN1
SCHEMBL15020116 0.70 PKM (0.56) GRM5PKMPOLBALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716125-A1 TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS AstraZeneca AB (SE) 2006-11-02 EP claimed
WO-2005080356-A1 TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS ASTRAZENECA AB (SE) 2005-09-01 WO claimed
WO-2009054785-A1 1,2,4-TRIAZOLE ETHER DERIVATIVES AS MODULATORS OF MGLUR5 ASTRAZENECA AB (SE) 2009-04-30 WO disclosed
EP-1716125-A1 TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS AstraZeneca AB (SE) 2006-11-02 EP disclosed
WO-2005080356-A1 TETRAZOLE COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONITS ASTRAZENECA AB (SE) 2005-09-01 WO disclosed